Trials 2
Author: A | 2025-04-24
GnarBike Trials 2 สำหรับ iPhone การดาวน์โหลดฟรีและปลอดภัย GnarBike Trials 2 เวอร์ชันล่าสุด GnarBike Trials 2 เป็นเกมแข่งรถจักรยานที่เต็มไปด้วยความตื่ I have the original Trials 2. How can I upgrade to Trials 2 Second Edition? If you bought and activated the original Trials 2 before Trials 2 Second Edition launch (5th March 2025), you can use your Trials 2 serial key to activate Trials 2 Second Edition. Download the Trials 2 demo and enter the activation key when asked.
Trials 2 - Play Trials 2 at Friv EZ
Was in development by another group, a review of entries in the Core Outcome Measures in Effectiveness Trials (COMET) initiative database was completed before commencing this project (( on 21 October 2016 and again before manuscript submission on 14 September 2017). No published or ongoing COS for the treatment of type 2 diabetes without co-morbidity was identified (Additional file 1).Here we aim to describe the outcomes used in trials, currently recruiting, that evaluate therapeutic interventions for type 2 diabetes, registered in a large international public clinical trial registry, as the first step in the development of a COS for type 2 diabetes [15].MethodsSearch strategyOn 20 October 2016, the ClinicalTrials.gov database (www.clinicaltrials.gov) was searched using the following search terms: Type 2 diabetes; Type II diabetes; non-insulin dependent diabetes; Open studies; Interventional studies; Phase 3, 4; Studies received from 10/11/2007.In the context of the clinicaltrials.gov registry, an ‘open’ study is one that is currently recruiting participants or will be recruiting participants in the future.Clinicaltrials.gov was chosen as this registry allows outcomes to be easily identified and extracted and was the main source of trials in a previous study using trial registries to identify outcomes [7]. Trials registered before 10 November 2007 have been reported elsewhere [7].Eligibility criteriaPhase 3 and 4 trials of therapeutic interventions for patients with type 2 diabetes were included. Trials were excluded if they met any of the following criteria: phase 1 and 2 trials (including entries listed as phase 2/phase 3); prevention trials; trials of treatment for diabetic foot ulcers, diabetic retinopathy or for diabetic nephropathy; trials of bariatric surgery; and trials of treatment for any other co-morbidity including non-alcoholic fatty liver disease and cardiovascular disease (trials assessing cardiovascular safety of glucose lowering drugs are eligible for inclusion). When trials were registered more than once, only the initial registration was included.Assessment of trial eligibilityNH and RJ reviewed the first 40 trials together with full discussion about inclusion and exclusion of trials and outcome extraction. A further 5% of trials was then randomly selected and independently reviewed in parallel by the reviewers to ensure consistency. Where disagreement was noted,
Trial 1 Trial 2 Trial 3 - Brainly.com
Team for BFAME Trials 2025 04:30-06:00 Semi Final 5 of 6 (2 tables) 06:30-08:00 Semi Final 6 of 6 (2 tables) Thursday, 2025-03-20 2025spring JAPAN intercollege championshipsTokyo, Japan 09:00-11:00 youngster match (2 tables) Thursday, 2025-03-20 Indian Senior Selection TrialsEllisbridge Gymkhana, India, India Selection of Seniors team for BFAME Trials 2025 09:15-10:45 Final 1 of 6 (2 tables) 11:15-12:45 Final 2 of 6 (2 tables) 13:15-14:45 Final 3 of 6 (2 tables) Thursday, 2025-03-20 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 15:00-17:30 Quarterfinals - quarter1 (8 tables) Peter Lund (Pelu) 17:30-20:00 Quarterfinals - quarter2 (8 tables) Peter Lund (Pelu) 21:00-23:30 Quarterfinals - quarter3 (8 tables) Peter Lund (Pelu) 23:30-02:00 Quarterfinals - quarter4 (8 tables) Friday, 2025-03-21 Indian Senior Selection TrialsEllisbridge Gymkhana, India, India Selection of Seniors team for BFAME Trials 2025 04:30-06:00 Final 4 of 6 (2 tables) 06:30-08:00 Final 5 of 6 (2 tables) 09:15-10:45 Final 6 of 6 (2 tables) Friday, 2025-03-21 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 13:30-15:00 Segment 1/14 Pair Tournament (2 tables) Friday, 2025-03-21 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 15:00-17:30 Semifinals - quarter1 (4 tables) Friday, 2025-03-21 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 15:10-16:40 Segment 2/14 Pair Tournament (2 tables) 16:50-18:20 Segment 3/14 Pair Tournament (2 tables) Friday, 2025-03-21 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 17:30-20:00 Semifinals - quarter2 (4 tables) Friday, 2025-03-21 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 18:30-20:00 Segment 4/14 Pair Tournament (2 tables) Friday, 2025-03-21 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 21:00-23:30 Semifinals - quarter3 (4 tables) Peter Lund (Pelu) 23:30-02:00 Semifinals - quarter4 (4 tables) Peter Lund (Pelu) Saturday, 2025-03-22 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 09:00-10:30 Segment 5/14 Pair Tournament (2 tables) 10:40-12:10 Segment 6/14 Pair Tournament (2 tables) 12:20-13:50 Segment 7/14 Pair Tournament (2 tables) Saturday, 2025-03-22 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 15:00-17:30 Finals - quarter1 (2 tables) Peter Lund (Pelu) Saturday, 2025-03-22 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 15:00-16:30 Segment 8/14 Pair Tournament (2 tables) 16:40-18:10 Segment 9/14 Pair Tournament (2 tables) Saturday, 2025-03-22 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 17:30-20:00 Finals - quarter2 (2 tables) Peter LundROBLOX - THE TRIALS // PHASE 2 (ALL TRIALS) // FASE 2
The reviewers discussed the study before reaching a decision. No study required third reviewer arbitration.Data extractionData on study characteristics was extracted by NH that included trial phase, region, design, type of intervention (pharmaceutical, nutritional, educational/lifestyle or device) and duration of follow-up. Data on outcomes listed in the clinicaltrials.gov protocol registration entry were extracted by NH and RJ from the specific outcomes fields and from the study information free text. Where composite outcomes were used, all component outcomes were included. Where an outcome was reported in terms of the measurement instrument used, for example a particular questionnaire, the instrument was reviewed and outcomes extracted.Outcome classificationNH categorised each outcome according to the COMET taxonomy of core domains [submitted for publication]. This taxonomy comprises 38 domains under five areas (death, physiological/clinical, life impact, resource use and adverse events). Functional outcomes were also categorised according to the ICF top level domains ( A random check of categorisation was completed on 30% of outcomes by JW, discrepancies were resolved through consensus and discussion with a third reviewer (PRW) where necessary.ResultsSearch results and study characteristicsThe search returned 675 entries in the clinicaltrials.gov database; after duplicates were removed, 354 trials were screened for eligibility, of which 138 were included (trial registration numbers of included trials are available in Additional file 2). The flow of included trials is shown in Fig. 1.Fig. 1Flow of included trialsFull size image Of the 138 eligible trials, 127 (92%) were trials of drug interventions with the remainder evaluating educational or lifestyle (4%), nutritional (2%) or device (1%) interventions. The majority (65%) were phase 4 trials with ≤ 200 participants (median = 135, range = 12–5000) and follow-up of ≤ 6 months (median = 24 weeks, range = 0–364 weeks). Characteristics of included trials are described in Table 1.Table 1 Description of included trialsFull size table Classification of trial outcomesCOMET taxonomyA total of 1444 individual outcomes were extracted with a median of eight outcomes per trial (range = 1–60). Each outcome was reviewed and categorised using the COMET taxonomy (Table 2).Table 2 Summary of outcomes categorised according to the COMET taxonomyFull size table. GnarBike Trials 2 สำหรับ iPhone การดาวน์โหลดฟรีและปลอดภัย GnarBike Trials 2 เวอร์ชันล่าสุด GnarBike Trials 2 เป็นเกมแข่งรถจักรยานที่เต็มไปด้วยความตื่ I have the original Trials 2. How can I upgrade to Trials 2 Second Edition? If you bought and activated the original Trials 2 before Trials 2 Second Edition launch (5th March 2025), you can use your Trials 2 serial key to activate Trials 2 Second Edition. Download the Trials 2 demo and enter the activation key when asked.Trials 2: Second Edition Download - Trials 2 SE is a
Review Open access Published: 15 December 2017 Rebecca James1, John Wilding2 & Paula R. Williamson1 on behalf of the SCORE-IT study team Trials volume 18, Article number: 597 (2017) Cite this article 2675 Accesses 13 Citations 4 Altmetric Metrics details AbstractBackgroundOutcomes measured in clinical trials should be meaningful to patients, healthcare professionals and researchers, yet there is heterogeneity in the outcomes used across trials. This inconsistency impacts on the ability to compare findings and may mean that the results have little importance to healthcare professionals and the patients that they care for. The aim of the present study is to review the outcomes used in registered trials of therapies for type 2 diabetes mellitus as the first step in the development of a core outcome set for effectiveness trials in type 2 diabetes.MethodsA systematic review of clinicaltrials.gov entries was completed for randomised, open (actively recruiting or in follow-up period), phase 3 and 4 trials of type 2 diabetes mellitus in adults. Trials of the treatment of diabetes complications, co-morbidities, prevention and surgery were excluded. Each trial was screened for eligibility and outcomes extracted from the primary and secondary outcomes data fields and free text study information. The outcomes were recorded verbatim and classified into core outcome domains according to the COMET taxonomy.ResultsA total of 354 trial registrations were reviewed for eligibility and 138 trials included. In total, 1444 outcomes were extracted with a median of eight outcomes per trial (range = 1–60). Outcomes were categorised into 30 different outcome domains according to the COMET taxonomy, but no single domain or outcome was measured in 100% of trials. The majority of trials (88%) included outcomes in the ‘metabolism and nutrition’ domain, such as lipids and lipoproteins (21%), HbA1c (18%), hypoglycaemia (14%), fasting plasma/blood glucose (11%), glycaemic variability (8%), postprandial response (8%) and insulin sensitivity (5%). Only 10% of trials included one or more patient reported outcomes; of these, 29% included the Diabetes Treatment Satisfaction Questionnaire.ConclusionsThere is marked heterogeneity in the outcomes measured in registered therapeutic intervention trials for type 2 diabetes. The use of an agreed set of core outcomes willSequential Trial 2 Guide for Adventurer's Trials Day 2
Require suppression of response Repeat NoGo: repeat of previous word and font color => require suppression of response Note: words can never be repeated unless by Repeat NoGo trials. Colors are chosen randomly in Stroop trials and could therefore repeat the color of the previous Go trial (but not the word). Similarly, Go trials could repeat the color of the preceding Stroop trial (but not the word). * Error Awareness Response: double clicking the response button in the Go trial following the commission error in NoGo trials * 900 trials total => In this script: 700 Go trials 50 Stroop trials (followed by 50 Go_afternogo trials) 50 Repeat trials (followed by 50 Go_afternogo trials) * 4 blocks of 225 trials: the sequence of Go and NoGo trials is predetermined and the same for each participant. (EDITABLE CODE -> Editable Lists -> list.trialsequence) - Each block contains roughly the same number of NoGo trials (odd blocks contain 12 Stroop/13 Repeat NoGo trials, even blocks contain 13 Stroop/12 Repeat NoGo trials) and 200 Go trials - there are 2-15 Go trials in between 2 NoGo trials in each block PRACTICE A practice block is provided (not original to Hester et al, 2007): 70 trials (controlled by list.trialsequence_practice) Participants receive errorfeedback a) after incorrect suppression of responses in Go trials and b) after incorrectly responding to NoGo trials. This feedback further includes a reminder to press the response key twice during the next trial to practice the error awareness response ___________________________________________________________________________________________________________________ INSTRUCTIONS ___________________________________________________________________________________________________________________ are not original. Edit under EDITABLE CODE -> Editable Instructions ___________________________________________________________________________________________________________________ EDITABLE CODE ___________________________________________________________________________________________________________________ check below for (relatively) easily editable parameters, stimuli, instructions etc. Keep in mind that you can use this script as a template and therefore always "mess" with the entire code to further customize your experiment. The parameters you can change are: /responsekey: the response key (default: " " -> spacebar) /fontsize_target: fontsize of the targets in screen height percentages (default: 10%) /fontsize_fixation: fontsize of the fixation mark in screen height percentages (default: 3%) /stimulusduration: presentation duration of the targets (default: 900ms) /ISIduration: interstimulus interval (default: 600ms) Note: in this script participants have stimulusduration + ISIduration to respond /skippractice: true = practice block is skipped false = practice block is run /trialsperblock: the number of trials in a block; computer uses this value to stop each block (default: 225) Note: if this number is changed, list.trialsequence might need to get updated accordinglyTrial Xtreme 2: All about Trial Xtreme 2 - Gameforge
Need to complete a specific number of Labyrinth Trials (usually 6) to unlock the Labyrinth at a particular difficulty (Normal, Cruel, Merciless). The required trials for each difficulty are scattered throughout the corresponding acts (e.g., Normal Labyrinth trials are found in Acts 1-3). Once you've completed the required trials for a difficulty, head to the statue at the top of the stairs in the town of Act 3 (usually Sarn) and interact with it to access the Labyrinth. By following these steps and keeping the tips in mind, you should be able to conquer Labyrinth Trials in Path of Exile with ease. 2. The Cruel Labyrinth Locations(Area level: 55)The Prison (Act 6), contains spike trapsThe Crypt (Act 7), contains spinning bladesThe Chamber of Sins Level 2 (Act 7), contains sawblades3. The Merciless Labyrinth Locations(Area level: 68)The Bath House, Act 8, contains furnace trapsThe Tunnel, Act 9, contains blade sentriesThe Ossuary, Act 10, contains dart trap4. The Eternal Labyrinth Locations(Area level: 75)Trial of Piercing Truth, contains spike trapsTrial of Swirling Fear, contains spinning bladesTrial of Crippling Grief, contains sawbladesTrial of Burning Rage, contains furnace trapsTrial of Lingering Pain, contains blade sentriesTrial of Stinging Doubt, contains dart trapsAccessing the Eternal Labyrinth no longer requires the completion of Trials of Ascendancy found in Maps, only the completion of previous Labyrinths. It still costs one Offering to the Goddess to access.The Eternal Labyrinth now requires a Character Level of 68 to access (previously 60).Trials of Ascendancy can no longer spawn in White Maps, and the ability to consume an Offering to the Goddess in the Map Device to open portals to a random Trial of Ascendancy has been removed.Buy PoE 2 Currency CheapPoE 2 Currency (6% off coupon: z123). Path of Exile item and currency. Payment: PayPal, Skrill, Cryptocurrencies.5. Traps5.1 Cleaver trapsCleaver traps are typically on narrow corridor paths, attached to the side. They consist of a large blade and wooden holding mechanism, and the blade slams down onto the corridor path every few seconds. They deal high amounts of physical damage on hit and apply a strong bleeding effect. Carefully time the bladesKoupit Gnarbike Trials 2 Nintendo Switch. Gnarbike Trials 2
Outcomes according to the ICF core set is provided in Additional files 3 and 4.DiscussionThere is heterogeneity in the outcomes used across registered open trials for type 2 diabetes. While some outcomes are commonly measured and are expected in trials that aim to treat hyperglycaemia, there is no consensus on which outcomes should be routinely measured and reported, with no single outcome or outcome domain being measured in all trials.Reaney et al. have recently reviewed PROMs used in published phase 3 type 2 diabetes mellitus trials of GLP-1 receptor agonists, novel insulins, SGLT-2 inhibitors and DPP-4 inhibitors [16]. The identified PROMs in the included studies were mixed and varied compared to those identified in the present review, with overlap of only four measurement instruments (DTSQ, EQ5D, SF-36 and HFS-11 worry scale). The diabetes treatment satisfaction questionnaire (DTSQ) was the most frequently used PROM in both the review by Reaney et al. and in the present study which may be due to the recommendations made by the WHO to encourage psychological wellbeing in patients with diabetes [17]. In the present study, only 10% of trials included a PROM; this is comparable with the study by Barsdorf et al. in 2012 who found that only 7.5% of phase 3 pharmaceutical interventions for type 2 diabetes, registered with clinical trials.gov, included a PROM [18]. Gandhi et al. [7] considered patient important outcomes in registered trials, described as outcomes that affect the way patients feel, function or survive [8]. In the present study, over half (51%) of trials included one or more outcomes meeting this definition. However, this definition was not developed with input from patients with type 2 diabetes and so may not truly reflect outcomes of treatment that they consider to be the most important.A limitation of the present study is that only one trials registry, clinicaltrials.gov, has been used. However, in the study by Gandhi et al., clinicaltrials.gov was the main registry source accounting for 81% of included studies [7]. In this study, only open (actively recruiting or will recruit in the near future) trials have been included, representing the current. GnarBike Trials 2 สำหรับ iPhone การดาวน์โหลดฟรีและปลอดภัย GnarBike Trials 2 เวอร์ชันล่าสุด GnarBike Trials 2 เป็นเกมแข่งรถจักรยานที่เต็มไปด้วยความตื่ I have the original Trials 2. How can I upgrade to Trials 2 Second Edition? If you bought and activated the original Trials 2 before Trials 2 Second Edition launch (5th March 2025), you can use your Trials 2 serial key to activate Trials 2 Second Edition. Download the Trials 2 demo and enter the activation key when asked.
Trials 2: Second Edition Download - Trials 2 SE is a fun game
Trials 2 Second Edition is a game where we ride our trial motorbike and have to ride it trying to reach the goal as fast as possible. In our way to the goal we'll have to overcome different obstacles. You'll enjoy in four different kinds of tracks: racing, flip, wheelie and dynamic physics tracks.Trials 2: Negotiate obstacles in the quickest time. Play games, win ourWorld money, and get clothing and accessories to create your own style.Trials 2 Second Edition - Demo v1.08Trials 2 Second Edtion is a skill based puzzle motorcycle racer in which you race through obstacle courses with the qickest time possible while trying to stay on your bike. If you like the demo the full game is available for only 10 bucks!RedLynx Trials 2 Second Edition is a spectacular motorcycle game featuring stunning graphics and addictive gameplay! 4 game types (race, flip, wheelie, dynamic)Race: Race against other players to compete levels as fast as possibleFlip: Try to make as many backflips or frontflips with your. Trials 2 Second Edition installer is used for installing both demo and full version of the game. Click the Download-button below to download the game. After installing the game, select 'Evaluate Demo' from the game activation dialog to run the demo version, or input your licensekey to activate the full version.Trials 2 Second Edition installer is used for installing both demo and full version of the game.After installing the game, select 'Evaluate Demo' from the game activation dialog to run the demo version, or input your licensekey to activate the full version. The full version serial key can be bought from the RedLynx Store and is delivered to you via e-mail.Updates to RedLynx’s hugely successful PC game, Trials 2 Second Edition, have been released. Specific additions include:Trials 2 Second Edition DemographicRedLynx TrialsTrials 2 Second Edition Icon, Trials 2 Second Edition, png
Use of outcomes in trials treating hyperglycaemia in patients with type 2 diabetes mellitus. Including only open trials has the advantage that the outcomes used reflect the current state of affairs in a particular research area. In a topic area as vast as type 2 diabetes, this has additional importance of not only the resource needed to review studies and generate an outcomes list but also ensuring that the outcomes included in a subsequent Delphi survey are relevant and do not represent outdated and redundant outcomes.A number of COSs exist for type 2 diabetes mellitus in clinical practice, but these too display heterogeneity in included outcomes [19]. The ICF COS [12] was developed using a consensus process and was designed for use in clinical practice although it has been suggested that the brief set of 28 items is suitable for use in clinical trials. However, the ICF set of 28 outcomes is impractical for use as a COS due to the large number of outcomes and the focus solely on function which may mean that it does not contain other outcomes important to patients with diabetes and health professionals caring for them.This review of current registered trials highlights the need for a COS for use in clinical trials of type 2 diabetes; it will contribute to a preliminary list of outcomes and outcome domains for use in the first round of an online Delphi survey to identify which outcomes are of importance to researchers, healthcare professionals and patients. AbbreviationsCOMET: Core Outcome Measures in Effectiveness Trials COS: Core outcome set DPP-4: Dipeptidyl peptidase-4 DTSQ: Diabetes Treatment Satisfaction Questionnaire GLP-1: Glucagon-like peptide 1 HbA1c: Glycated haemoglobin ICF: International Classification of Functioning, Disability and Health PROM: Patient-reported outcome measure SGLT 2: Sodium-glucose co-transporter 2 WHO: World Health Organization ReferencesMeigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore longitudinal study of aging. Diabetes. 2003;52:1475–84.Article CAS PubMed Google Scholar American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–9.Article PubMed Central Google Scholar Black C, Donnelly. GnarBike Trials 2 สำหรับ iPhone การดาวน์โหลดฟรีและปลอดภัย GnarBike Trials 2 เวอร์ชันล่าสุด GnarBike Trials 2 เป็นเกมแข่งรถจักรยานที่เต็มไปด้วยความตื่ I have the original Trials 2. How can I upgrade to Trials 2 Second Edition? If you bought and activated the original Trials 2 before Trials 2 Second Edition launch (5th March 2025), you can use your Trials 2 serial key to activate Trials 2 Second Edition. Download the Trials 2 demo and enter the activation key when asked.Trials 2: Second Edition: All about Trials 2: Second Edition
Trials 2 Second Edition 1.08 PC Installer Trials 2 Second Edition installer is used for installing both demo and full version of the game. Click the Download-button below to download the game. After installing the game, select "Evaluate Demo" from the game activation dialog to run the demo version, or input your licensekey to activate the full version. The full version serial key can be bought from the RedLynx Store and is delivered to you via e-mail. Download mirrors: Trials 2 SE 1.07 (RedLynx EU mirror) Trials 2 SE 1.07 (RedLynx US mirror) --> Bittorrent download: Trials 2 SE 1.07 (Mininova) --> System Requirements Minimum System Requirements Operating system: Windows XP (32-bit) or Windows Vista (32-bit or 64-bit) CPU Intel Pentium 3 600 Mhz or better AMD Athlon XP or better Ultra low voltage CPUs (Intel ATOM, VIA C7/Nano) 1.2 GHz or better RAM: 256 MB A DX9 graphics card with at least 64 megabytes of memory: Nvidia GeForce FX 5200 or better ATI Radeon 9500 or better Intel GMA 900 or better VIA/S3 Chrome 9 or better Free hard disk space: 220 MB An internet connection for activating the game Recommended System Operating system: Windows XP (32-bit) or Windows Vista (32-bit or 64-bit) CPU: 1,5 GHz Intel Pentium 4, AMD Athlon XP 1500+ or higher RAM: 512 MB Graphics card in one of the following categories, with at least 256 MB of memory: Nvidia GeForce 7600 or higher ATI Radeon X1600 or higher Free hard disk space: 220 MB A sound card An internet connection for activating the game and using the online featuresComments
Was in development by another group, a review of entries in the Core Outcome Measures in Effectiveness Trials (COMET) initiative database was completed before commencing this project (( on 21 October 2016 and again before manuscript submission on 14 September 2017). No published or ongoing COS for the treatment of type 2 diabetes without co-morbidity was identified (Additional file 1).Here we aim to describe the outcomes used in trials, currently recruiting, that evaluate therapeutic interventions for type 2 diabetes, registered in a large international public clinical trial registry, as the first step in the development of a COS for type 2 diabetes [15].MethodsSearch strategyOn 20 October 2016, the ClinicalTrials.gov database (www.clinicaltrials.gov) was searched using the following search terms: Type 2 diabetes; Type II diabetes; non-insulin dependent diabetes; Open studies; Interventional studies; Phase 3, 4; Studies received from 10/11/2007.In the context of the clinicaltrials.gov registry, an ‘open’ study is one that is currently recruiting participants or will be recruiting participants in the future.Clinicaltrials.gov was chosen as this registry allows outcomes to be easily identified and extracted and was the main source of trials in a previous study using trial registries to identify outcomes [7]. Trials registered before 10 November 2007 have been reported elsewhere [7].Eligibility criteriaPhase 3 and 4 trials of therapeutic interventions for patients with type 2 diabetes were included. Trials were excluded if they met any of the following criteria: phase 1 and 2 trials (including entries listed as phase 2/phase 3); prevention trials; trials of treatment for diabetic foot ulcers, diabetic retinopathy or for diabetic nephropathy; trials of bariatric surgery; and trials of treatment for any other co-morbidity including non-alcoholic fatty liver disease and cardiovascular disease (trials assessing cardiovascular safety of glucose lowering drugs are eligible for inclusion). When trials were registered more than once, only the initial registration was included.Assessment of trial eligibilityNH and RJ reviewed the first 40 trials together with full discussion about inclusion and exclusion of trials and outcome extraction. A further 5% of trials was then randomly selected and independently reviewed in parallel by the reviewers to ensure consistency. Where disagreement was noted,
2025-04-17Team for BFAME Trials 2025 04:30-06:00 Semi Final 5 of 6 (2 tables) 06:30-08:00 Semi Final 6 of 6 (2 tables) Thursday, 2025-03-20 2025spring JAPAN intercollege championshipsTokyo, Japan 09:00-11:00 youngster match (2 tables) Thursday, 2025-03-20 Indian Senior Selection TrialsEllisbridge Gymkhana, India, India Selection of Seniors team for BFAME Trials 2025 09:15-10:45 Final 1 of 6 (2 tables) 11:15-12:45 Final 2 of 6 (2 tables) 13:15-14:45 Final 3 of 6 (2 tables) Thursday, 2025-03-20 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 15:00-17:30 Quarterfinals - quarter1 (8 tables) Peter Lund (Pelu) 17:30-20:00 Quarterfinals - quarter2 (8 tables) Peter Lund (Pelu) 21:00-23:30 Quarterfinals - quarter3 (8 tables) Peter Lund (Pelu) 23:30-02:00 Quarterfinals - quarter4 (8 tables) Friday, 2025-03-21 Indian Senior Selection TrialsEllisbridge Gymkhana, India, India Selection of Seniors team for BFAME Trials 2025 04:30-06:00 Final 4 of 6 (2 tables) 06:30-08:00 Final 5 of 6 (2 tables) 09:15-10:45 Final 6 of 6 (2 tables) Friday, 2025-03-21 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 13:30-15:00 Segment 1/14 Pair Tournament (2 tables) Friday, 2025-03-21 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 15:00-17:30 Semifinals - quarter1 (4 tables) Friday, 2025-03-21 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 15:10-16:40 Segment 2/14 Pair Tournament (2 tables) 16:50-18:20 Segment 3/14 Pair Tournament (2 tables) Friday, 2025-03-21 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 17:30-20:00 Semifinals - quarter2 (4 tables) Friday, 2025-03-21 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 18:30-20:00 Segment 4/14 Pair Tournament (2 tables) Friday, 2025-03-21 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 21:00-23:30 Semifinals - quarter3 (4 tables) Peter Lund (Pelu) 23:30-02:00 Semifinals - quarter4 (4 tables) Peter Lund (Pelu) Saturday, 2025-03-22 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 09:00-10:30 Segment 5/14 Pair Tournament (2 tables) 10:40-12:10 Segment 6/14 Pair Tournament (2 tables) 12:20-13:50 Segment 7/14 Pair Tournament (2 tables) Saturday, 2025-03-22 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 15:00-17:30 Finals - quarter1 (2 tables) Peter Lund (Pelu) Saturday, 2025-03-22 Poland Trials U-21 Final Warsaw, Poland Poland Trials U-21 Final 15:00-16:30 Segment 8/14 Pair Tournament (2 tables) 16:40-18:10 Segment 9/14 Pair Tournament (2 tables) Saturday, 2025-03-22 2025 Vanderbilt TeamsMemphis, TN, United States Spring NABC Knockout - NOTE: Schedule subject to change, depending on how many teams register 17:30-20:00 Finals - quarter2 (2 tables) Peter Lund
2025-03-30Review Open access Published: 15 December 2017 Rebecca James1, John Wilding2 & Paula R. Williamson1 on behalf of the SCORE-IT study team Trials volume 18, Article number: 597 (2017) Cite this article 2675 Accesses 13 Citations 4 Altmetric Metrics details AbstractBackgroundOutcomes measured in clinical trials should be meaningful to patients, healthcare professionals and researchers, yet there is heterogeneity in the outcomes used across trials. This inconsistency impacts on the ability to compare findings and may mean that the results have little importance to healthcare professionals and the patients that they care for. The aim of the present study is to review the outcomes used in registered trials of therapies for type 2 diabetes mellitus as the first step in the development of a core outcome set for effectiveness trials in type 2 diabetes.MethodsA systematic review of clinicaltrials.gov entries was completed for randomised, open (actively recruiting or in follow-up period), phase 3 and 4 trials of type 2 diabetes mellitus in adults. Trials of the treatment of diabetes complications, co-morbidities, prevention and surgery were excluded. Each trial was screened for eligibility and outcomes extracted from the primary and secondary outcomes data fields and free text study information. The outcomes were recorded verbatim and classified into core outcome domains according to the COMET taxonomy.ResultsA total of 354 trial registrations were reviewed for eligibility and 138 trials included. In total, 1444 outcomes were extracted with a median of eight outcomes per trial (range = 1–60). Outcomes were categorised into 30 different outcome domains according to the COMET taxonomy, but no single domain or outcome was measured in 100% of trials. The majority of trials (88%) included outcomes in the ‘metabolism and nutrition’ domain, such as lipids and lipoproteins (21%), HbA1c (18%), hypoglycaemia (14%), fasting plasma/blood glucose (11%), glycaemic variability (8%), postprandial response (8%) and insulin sensitivity (5%). Only 10% of trials included one or more patient reported outcomes; of these, 29% included the Diabetes Treatment Satisfaction Questionnaire.ConclusionsThere is marked heterogeneity in the outcomes measured in registered therapeutic intervention trials for type 2 diabetes. The use of an agreed set of core outcomes will
2025-04-14